TFPIβ, a Second Product from the Mouse Tissue Factor Pathway Inhibitor (TFPI) Gene

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Thrombosis and Haemostasis

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1055/s-0037-1614416PMID 9974373
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cloning, Expression, and Characterization of Mouse Tissue Factor Pathway Inhibitor (TFPI)

  1998influential reference
• Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice.

  1997cited by this paper
• An anti-tissue factor pathway inhibitor (TFPI) monoclonal antibody recognized the third Kunitz domain (K3) of free-form TFPI but not lipoprotein-associated forms in plasma.

  1995cited by this paper
• Tissue factor pathway inhibitor activity in human plasma. Measurement of lipoprotein-associated and free forms in hyperlipidemia.

  1995cited by this paper
• Effect of heparin on the inhibition of factor Xa by tissue factor pathway inhibitor: a segment, Gly212-Phe243, of the third Kunitz domain is a heparin-binding site.

  1995cited by this paper
• Complementary DNA sequencing of canine tissue factor pathway inhibitor reveals a unique nanomeric repetitive sequence between the second and third Kunitz domains.

  1994cited by this paper
• Split genes and RNA splicing.

  1994cited by this paper
• Amino acid sequence and inhibitory activity of rhesus monkey tissue factor pathway inhibitor (TFPI): comparison with human TFPI.

  1994cited by this paper
• Evidence that the C-terminus of tissue factor pathway inhibitor (TFPI) is essential for its in vitro and in vivo interaction with lipoproteins.

  1993cited by this paper
• Structural requirements for tissue factor pathway inhibitor interactions with factor Xa and heparin.

  1993cited by this paper
• Kinetics of factor Xa inhibition by tissue factor pathway inhibitor.

  1993cited by this paper
• Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa.

  1992cited by this paper
• cDNA cloning and expression of rat tissue factor pathway inhibitor (TFPI).

  1992cited by this paper
• RNA binding proteins, splice site selection, and alternative pre-mRNA splicing.

  1992cited by this paper
• The Atlas of Mouse Development

  1992cited by this paper
• Purification and properties of heparin-releasable lipoprotein-associated coagulation inhibitor.

  1991cited by this paper
• Mechanisms of alternative pre-mRNA splicing.

  1991cited by this paper
• LP(a) as a marker for coronary heart disease risk

  1991cited by this paper
• cDNA sequence of rabbit lipoprotein-associated coagulation inhibitor.

  1990cited by this paper
• Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis.

  1990cited by this paper
• Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma.

  1989cited by this paper
• Identification of the 1.4 kb and 4.0 kb messages for the lipoprotein associated coagulation inhibitor and expression of the encoded protein.

  1989cited by this paper
• Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor

  1989cited by this paper
• Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor.

  1988cited by this paper
• Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains.

  1988cited by this paper
• Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor

  1988cited by this paper
• Low-density lipoprotein subclass patterns and risk of myocardial infarction.

  1988cited by this paper
• Heparin induces release of extrinsic coagulation pathway inhibitor (EPI).

  1988cited by this paper
• Complex transcriptional units: diversity in gene expression by alternative RNA processing.

  1986cited by this paper
• Identifying nonpolar transbilayer helices in amino acid sequences of membrane proteins.

  1986cited by this paper
• High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

  1977cited by this paper
• DNA sequencing with chain-terminating inhibitors.

  1977cited by this paper

• Placental Vascular Defects and Embryonic Lethality Triggered by TFPIα Deficiency in Factor V Leiden Mice.

  2025cites this paper
• The Tissue Factor Pathway in Cancer: Overview and Role of Heparan Sulfate Proteoglycans

  2023cites this paper
• Intrauterine lethality in Tfpi gene disrupted mice is differentially suppressed during mid‐ and late‐gestation by platelet TFPIα overexpression

  2021cites this paper
• Major Reservoir for Heparin-Releasable TFPIα (Tissue Factor Pathway Inhibitor α) Is Extracellular Matrix

  2021cites this paper
• Pharmacological and clinical application of heparin progress: An essential drug for modern medicine.

  2021cites this paper
• The contribution of TFPIα to the hemostatic response to injury in mice

  2021cites this paper
• Re‐evaluation of mouse tissue factor pathway inhibitor and comparison of mouse and human tissue factor pathway inhibitor physiology

  2018cites this paper
• Post-transcriptional, post-translational and pharmacological regulation of tissue factor pathway inhibitor.

  2018cites this paper
• TFPI (Tissue Factor Pathway Inhibitor)

  2018cites this paper
• Platelet-Mediated Modulation of Fibrinolysis

  2017cites this paper
• Targeting TFPI for hemophilia treatment.

  2016cites this paper
• Polyphosphate is a novel modulator of coagulation and inflammation and is a therapeutic target

  2015cites this paper
• How it all starts: Initiation of the clotting cascade

  2015influential citation
• Syndecan-3 and TFPI Colocalize on the Surface of Endothelial-, Smooth Muscle-, and Cancer Cells

  2015cites this paper
• Tissue factor‐independent inhibition of thrombin generation by tissue factor pathway inhibitor‐α

  2015cites this paper
• Role of exosite binding modulators in the inhibition of Fxa by TFPI

  2015cites this paper
• The role of the different Kunitz domains of TFPI in the down-regulation of the extrinsic coagulation pathway

  2015cites this paper
• Biology of tissue factor pathway inhibitor.

  2014cites this paper
• Tissue Factor Pathway Inhibitor: Then and Now

  2014cites this paper
• Inhibition of tissue factor:factor VIIa–catalyzed factor IX and factor X activation by TFPI and TFPI constructs

  2014cites this paper
• Target-mediated clearance and bio-distribution of a monoclonal antibody against the Kunitz-type protease inhibitor 2 domain of Tissue Factor Pathway Inhibitor.

  2014cites this paper
• Inhibitory effects of LDL-associated tissue factor pathway inhibitor.

  2014cites this paper
• Translation of Human Tissue Factor Pathway Inhibitor-&bgr; mRNA Is Controlled by Alternative Splicing Within the 5′ Untranslated Region

  2014cites this paper
• Protein S Is a Cofactor for Platelet and Endothelial Tissue Factor Pathway Inhibitor-&agr; but Not for Cell Surface–Associated Tissue Factor Pathway Inhibitor

  2014cites this paper
• required for embryonic development and hemostasis in adult mice A balance between tissue factor and tissue factor pathway inhibitor is

  2013cites this paper
• Mast Paul E . R . Ellery , Susan A . Maroney , Nicholas D . Martinez , Marvin P . Wickens and Alan E . Untranslated Region ′ Alternative Splicing Within the 5 mRNA Is Controlled

  2013cites this paper
• TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity

  2013cites this paper
• Comparison of the inhibitory activities of human tissue factor pathway inhibitor (TFPI)α and TFPIβ

  2013cites this paper
• Cellular expression and biological activities of alternatively spliced forms of tissue factor pathway inhibitor

  2013cites this paper
• Conception rationnelle de nouvelles protéines thérapeutiques dans l'hémophilie : variants du facteur Xa dépourvus du domaine Gla

  2013cites this paper
• Tissue factor pathway inhibitor: structure-function.

  2012influential citation
• Caveolae optimize tissue factor-Factor VIIa inhibitory activity of cell-surface-associated tissue factor pathway inhibitor.

  2012cites this paper
• Platelet tissue factor pathway inhibitor modulates intravascular coagulation.

  2012influential citation
• Tissue Factor Pathway Inhibitor Blocks Angiogenesis via Its Carboxyl Terminus

  2012cites this paper
• Alternatively spliced tissue factor pathway inhibitor: functional implications.

  2011cites this paper
• The role of TFPI in regulation of TF-induced thrombogenicity on the surface of human monocytes.

  2010cites this paper
• Endothelial-derived tissue factor pathway inhibitor regulates arterial thrombosis but is not required for development or hemostasis.

  2010cites this paper
• Tissue Factor Pathway

  2010cites this paper
• Alternatively spliced isoforms of tissue factor pathway inhibitor.

  2010cites this paper
• Temporal expression of alternatively spliced forms of tissue factor pathway inhibitor in mice

  2009cites this paper
• Association of Asn221Ser mutation in tissue factor pathway inhibitor-β with plasma total tissue factor pathway inhibitor level

  2009cites this paper
• Tissue Factor Pathway Inhibitor: Structure and Function

  2008cites this paper
• Further Insight Into the Heparin-Releasable and Glycosylphosphatidylinositol-Lipid— Anchored Forms of Tissue Factor Pathway Inhibitor

  2008cites this paper
• Tissue factor pathway inhibitor‐γ is an active alternatively spliced form of tissue factor pathway inhibitor present in mice but not in humans

  2008cites this paper
• Expression of tissue factor pathway inhibitor by endothelial cells and platelets.

  2008cites this paper
• Fibronectin‐adherent monocytes express tissue factor and tissue factor pathway inhibitor whereas endotoxin‐stimulated monocytes primarily express tissue factor: physiologic and pathologic implications

  2007cites this paper
• The tissue factor–factor VIIa complex: procoagulant activity, regulation, and multitasking

  2007cites this paper
• A guide to murine coagulation factor structure, function, assays, and genetic alterations

  2007cites this paper
• Sepsis-induced coagulation in the baboon lung is associated with decreased tissue factor pathway inhibitor.

  2007cites this paper
• The Role of Tissue Factor Pathway Inhibitor in Tumor Growth and Metastasis

  2007cites this paper
• Active tissue factor pathway inhibitor is expressed on the surface of coated platelets.

  2007cites this paper
• The role of tissue factor pathway inhibitor in tumor growth and metastasis.

  2007cites this paper
• The haemostatic role of tissue factor pathway inhibitor.

  2007cites this paper
• Identification and characterization of murine alternatively spliced tissue factor

  2006cites this paper
• Disposition of tissue factor pathway inhibitor during cardiopulmonary bypass

  2006cites this paper
• Tissue factor initiated blood coagulation.

  2006cites this paper
• Blood coagulation and alternative pre-mRNA splicing: an overview.

  2006cites this paper
• A GPI‐anchored co‐receptor for tissue factor pathway inhibitor controls its intracellular trafficking and cell surface expression

  2006cites this paper
• A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice.

  2005cites this paper
• Comparison of cell‐surface TFPIα and β

  2005cites this paper
• Role for the Kunitz-3 Domain of Tissue Factor Pathway Inhibitor-&agr; in Cell Surface Binding

  2004cites this paper
• Tissue factor pathway inhibitor revisited

  2004cites this paper
• Glycosyl Phosphatidylinositol Anchorage of Tissue Factor Pathway Inhibitor

  2003cites this paper
• Structure and Biology of Tissue Factor Pathway Inhibitor

  2001cites this paper
• Synthesis and Expression of Tissue Factor Pathway Inhibitor by Serum-stimulated Fibroblasts, Vascular Smooth Muscle Cells and Cardiac Myocytes

  1999cites this paper